Showing 1 - 8 results of 8 for search 'Stephane Chauvie', query time: 0.03s Refine Results
  1. 1
    The Strategies to Homogenize PET/CT Metrics: The Case of Onco-Haematological Clinical Trials

    The Strategies to Homogenize PET/CT Metrics: The Case of Onco-Haematological Clinical Trials by Stephane Chauvie, Fabrizio Bergesio

    Published 2016-11-01
    Get full text
    Article
  2. 2
    A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation

    A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation by Stephane Chauvie, Lorenzo Nicola Mazzoni, Jim O’Doherty

    Published 2023-10-01
    Get full text
    Article
  3. 3
    Myocardial Metabolic Response Predicts Chemotherapy Curative Potential on Hodgkin Lymphoma: A Proof-of-Concept Study

    Myocardial Metabolic Response Predicts Chemotherapy Curative Potential on Hodgkin Lymphoma: A Proof-of-Concept Study by Cecilia Marini, Matteo Bauckneht, Anna Borra, Rita Lai, Maria Isabella Donegani, Alberto Miceli, Cristina Campi, Vanessa Cossu, Daniela Schenone, Silvia Morbelli, Stephane Chauvie, Michele Piana, Andrea Gallamini, Gianmario Sambuceti

    Published 2021-08-01
    Get full text
    Article
  4. 4
    A prognostic model integrating PET‐derived metrics and image texture analyses with clinical risk factors from GOYA

    A prognostic model integrating PET‐derived metrics and image texture analyses with clinical risk factors from GOYA by Lale Kostakoglu, Federico Dalmasso, Paola Berchialla, Larry A. Pierce, Umberto Vitolo, Maurizio Martelli, Laurie H. Sehn, Marek Trněný, Tina G. Nielsen, Christopher R. Bolen, Deniz Sahin, Calvin Lee, Tarec Christoffer El‐Galaly, Federico Mattiello, Paul E. Kinahan, Stephane Chauvie

    Published 2022-05-01
    Get full text
    Article
  5. 5
    P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials

    P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patie... by Simonetta Viviani, Chiara Pavoni, Sally F. Barrington, Luca Guerra, Heiko Schöder, Peter Johnson, Amy A. Kirkwood, Deborah M. Stephens, Jonathan W. Friedberg, Stephane Chauvie, Michael V. Knopp, Massimo Federico, Gunilla Enblad, Paolo Corradini, Andrea Gallamini, Alessandro Rambaldi, Corrado Tarella

    Published 2022-10-01
    Get full text
    Article
  6. 6
    T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial.

    T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Tri... by Andrea Gallamini, Marco Picardi, Kateryna Filonenko, Manuel Gotti, Javier Núñez Céspedes, Andrea Rossi, Eva Domingo-Domènech, Agnieszka Giza, Roberto Sorasio, Livio Trentin, Mariana Bastos Oteiro, Ewa Paszkiewicz-Kozik, Ramon García Sanz, Caterina Patti, Stephane Chauvie, Fabrizio Bergesio, Luca Guerra, Alessandro Rambaldi, Ana Sureda Balari, Jan Maciej Zaucha

    Published 2022-10-01
    Get full text
    Article
  7. 7
    P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untreated limited-stage classical Hodgkin lymphoma

    P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untre... by John Radford, Toyin Adedayo, Arzhang Ardavan, Sally F. Barrington, Leanne Berkahn, Stephane Chauvie, Laura Clifton-Hadley, Graham P. Collins, Michael Crump, David Cutter, Darren Edwards, Martin Hutchings, Tim Illidge, Amy A. Kirkwood, Kim Linton, Craig H. Moskowitz, Pip Patrick, Beth Phillips, Lois Shepherd, Sanne Tonino, Judith Trotman, Joanna Williams, Nicole Wong Doo

    Published 2022-10-01
    Get full text
    Article
  8. 8
    S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)

    S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMIS... by Maurizio Martelli, Luca Ceriani, Emanuele Zucca, Irina Kryachok, Giovannino Ciccone, Umberto Ricardi, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Sara Veronica Usai, Elsa Pennese, Luca Arcaini, Anna Dabrowska-Iwanicka, Andrés José María Ferreri, Francesco Marli, Weili Zhao, David Hodgson, Codruta Ionescu, Luigi Rigacci, Claudia Cellini, Caterina Stelitano, Francesco Zaja, Attilio Guarini, Michele Spina, Alexander Fossa, Kate Cwynarski, N. George Mikhaeel, Mats Jerkeman, Andrea Janíková, Andreas Huettmann, Maria Gomes Da Silva, Don Stevens, Luigi Petrucci, Sally Barrington, Bogdan Malkowski, Ur Metser, Annibale Versari, Oreste Bagni, Stephane Chauvie, Kelly Cozens, Sonia Perticone, Nicoletta Ielmini, Franco Cavalli, Mary Gosodarowicz, Peter W. Johnson, Andrew Davies

    Published 2023-08-01
    Get full text
    Article

Search Tools: